Replies to post #337432 on Anavex Life Sciences Corp (AVXL)

[James salmon]

I liked the part where he stated extension study had been extended at request of patients and physicians to 3 years and that I think he said 94% of placebo arm had entered the extension study.

Also cash on hand to 2025.